NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates

Hironori Satoh1, Takashi Moriguchi2, Daisuke Saigusa3

  • 1Department of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan. Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.

Cancer Research
|March 30, 2016
PubMed

Insights

High Nrf2 levels protect against lung cancer by enhancing detoxification. However, Nrf2 also promotes tumor growth, suggesting a complex role in cancer development and immunity.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) activation has dual roles in cancer: chemoprevention and promoting malignant characteristics.
  • Understanding Nrf2's contradictory functions is crucial for cancer therapy development.
  • This study investigates Nrf2's role in urethane-induced lung carcinogenesis in mice.

Purpose of the Study:

  • To reconcile the opposing roles of Nrf2 in cancer chemoprevention and cancer cell growth.
  • To examine the impact of global Nrf2 activation on lung tumor development and progression.
  • To elucidate the mechanisms underlying Nrf2's dual effects in a carcinogenesis model.

Main Methods:

  • Utilized Keap1-knockdown (kd) mice with high Nrf2 expression.
  • Administered urethane to induce lung carcinogenesis.
  • Assessed tumor incidence and size in Keap1-kd and wild-type mice.
  • Performed tumor cell transplantation into nude mice to evaluate tumorigenicity.
  • Conducted microarray analysis to identify differentially expressed genes in tumors.

Main Results:

  • Keap1-kd mice showed rapid urethane excretion and reduced tumor frequency/size due to enhanced detoxification.
  • Tumor cells derived from Keap1-kd mice exhibited increased tumorigenicity in transplantation models.
  • Microarray analysis revealed upregulation of antioxidative stress genes in Keap1-kd-derived tumors.

Conclusions:

  • Nrf2 activation enhances cancer cell tumorigenicity but also boosts anticancer immunity when globally activated.
  • Global Nrf2 activation suppresses tumor growth potential by enhancing anticancer immunity.
  • Nrf2 plays a complex, stage-dependent role in carcinogenesis, requiring further investigation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
41.9K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
5.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K